Ultra-Deep Targeted Sequencing Does Not Identify MM Patients with Different Prognosis: Results from a Randomized Phase II Clinical Trial

被引：0
|
作者：
Ruiz-Heredia, Yanira
Martinez-Lopez, Joaquin
Martinez-Avila, Jose Carlos
Sanchez-Vega, Beatriz
Rapado, Inmaculada
Jimenez, Cristina
Braggio, Esteban
Martinez, Rafael
Rosinol, Laura
Ocio, Enrique M.
Echeveste, M. Asuncion
de Oteyza, Jaime Perez
Oriol, Albert
Bargay, Joan
Gironella, Mercedes
Martin, Jesus
Ayala, Rosa M.
Blade, Joan
Stewart, Keith
Mateos, Maria-Victoria
Miguel, Jesus San
Garcia-Sanz, Ramon
Lahuerta, Juan Jose
Aguirre, Xabier
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2078.2078
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2078
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: Preliminary results from a randomized phase II clinical trial from Germany
    Bennett, CL
    Lane, D
    Stinson, T
    Glatzel, M
    Buntzel, J
    CANCER INVESTIGATION, 2001, 19 (02) : 107 - 113
  • [22] Effects of brodalumab on anxiety and depression in patients with psoriasis: Results from a phase 3 randomized controlled clinical trial
    Gooderham, Melinda
    Feldman, Steven R.
    Harris, Susan
    Rastogi, Shipra
    Israel, Robert J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB118 - AB118
  • [23] Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial
    Della Bella, Paolo
    Baratto, Francesca
    Vergara, Pasquale
    Bertocchi, Patrizia
    Santamaria, Matteo
    Notarstefano, Pasquale
    Calo, Leonardo
    Orsida, Daniela
    Tomasi, Luca
    Piacenti, Marcello
    Sangiorgio, Stefano
    Pentimalli, Francesco
    Pruvot, Etienne
    de Sousa, Joao
    Sacher, Frederic
    Tritto, Massimo
    Rebellato, Luca
    Deneke, Thomas
    Romano, Salvo Andrea
    Nesti, Martina
    Gargaro, Alessio
    Giacopelli, Daniele
    Peretto, Giovanni
    Radinovic, Andrea
    CIRCULATION, 2022, 145 (25) : 1829 - 1838
  • [24] Combination therapy of envafolimab and suvemcitug in patients with hepatocellular carcinoma (HCC): Results from a phase II clinical trial
    Ma, L.
    Zhang, Y.
    Fang, Y.
    Hao, C.
    Fan, Q.
    Jiang, D.
    Lu, L.
    Su, F.
    Yang, C.
    Liu, Z.
    Tian, J.
    Sun, X.
    Sun, S.
    Cheng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S599 - S600
  • [25] Detection of minimal residual disease (MRD) in colorectal cancer (CRC) patients UICC stage II/III by ultra-deep sequencing of cfDNA from post-surgery plasma
    McNamara, Sylvie
    Patel, Rajesh D.
    Adams, Hans-Peter
    Qu, Xueping
    Hinzmann, Bernd
    Wong, Cheryl V.
    Heilek, Gabrielle
    Mantke, Rene
    Heise, Michael
    Steinmueller, Thomas
    Pross, Matthias
    Marusch, Frank
    Bais, Carlos
    Palma, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [26] Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: Results of the SHIVA trial
    Le Tourneau, Christophe
    Delord, Jean-Pierre
    Goncalves, Anthony
    Gavoille, Celine
    Dubot, Coraline
    Isambert, Nicolas
    Campone, Mario
    Tredan, Olivier
    Mauborgne, Cecile
    Armanet, Sebastien
    Servant, Nicolas
    Bieche, Ivan
    Bernard, Virginie
    Gentien, David
    Jezequel, Pascal
    Attignon, Valery
    Boyault, Sandrine
    Vincent-Salomon, Anne
    Kamal, Maud
    Paoletti, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Re: Posterior Rhabdosphincter Reconstruction During Robotic Assisted Radical Prostatectomy: Results from a Phase II Randomized Clinical Trial
    Coelho, Rafael Ferreira
    Chauhan, Sanket
    Patel, Vipul R.
    EUROPEAN UROLOGY, 2011, 60 (01) : 180 - 181
  • [28] Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial
    Multhoff, Gabriele
    Seier, Sophie
    Stangl, Stefan
    Sievert, Wolfgang
    Shevtsov, Maxim
    Werner, Caroline
    Pockley, A. Graham
    Blankenstein, Christiane
    Hildebrandt, Martin
    Offner, Robert
    Ahrens, Norbert
    Kokowski, Konrad
    Hautmann, Matthias
    Roedel, Claus
    Fietkau, Rainer
    Lubgan, Dorota
    Huber, Rudolf
    Hautmann, Hubert
    Duell, Thomas
    Molls, Michael
    Specht, Hanno
    Haller, Bernhard
    Devecka, Michal
    Sauter, Andreas
    Combs, Stephanie E.
    CLINICAL CANCER RESEARCH, 2020, 26 (20) : 5368 - 5379
  • [29] Does Vitamin E Mitigate Cisplatin-induced Nephrotoxicity in Cancer Patients: Results from a Randomized PlaceboControlled Clinical Trial
    Ashrafi, Farzaneh
    Tabiei, Mohammad Naeimi
    Mousavi, Sarah
    Nematbakhsh, Mehdi
    Sotoodehnasab, Parisa
    Janbabaei, Ghasem
    MIDDLE EAST JOURNAL OF CANCER, 2020, 11 (02) : 174 - 184
  • [30] Cancer regression induced by TLR9-targeted inummostimulatory CpG treatment in patients with metastatic melanoma: results of a clinical phase II trial
    Pashenkov, M
    Goess, G
    Wagner, C
    Schneeberger, W
    Krieg, AM
    Stingl, G
    Wagner, SN
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A58 - A58
12345